High mobility group box 1 and angiogenetic growth factor levels in children with central nerve system infections

Shinichiro Morichi1, Gaku Yamanaka1, Yusuke Watanabe1

  • 1Department of Pediatrics and Adolescent Medicine, Tokyo Medical University.

Insights

High-mobility group box 1 (HMGB1) and angiogenesis factors are elevated in pediatric central nervous system (CNS) infections like encephalopathy and meningitis. These molecules play key roles in the pathology of these serious childhood neurological disorders.

Area of Science:

  • Pediatric Neurology
  • Neuroinflammation
  • Molecular Biology

Background:

  • High-mobility group box 1 (HMGB1) is a key danger-associated molecular pattern.
  • Angiogenesis-related growth factors are crucial in physiological and pathological processes.
  • Understanding their role in pediatric neurological disorders is essential for clarifying disease mechanisms.

Purpose of the Study:

  • To investigate the involvement of HMGB1 and angiogenesis-related growth factors in children with acute encephalopathy and other neurological disorders.
  • To compare levels of these molecules in patients with central nervous system (CNS) infections versus controls.

Main Methods:

  • Studied 12 children with acute encephalopathy, 7 with bacterial meningitis, and 6 with West syndrome (epilepsy).
  • Included 24 control patients with non-CNS infections.
  • Measured serum and cerebrospinal fluid (CSF) levels of HMGB1, platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF).

Main Results:

  • Significantly higher serum and CSF HMGB1 levels were observed in encephalopathy and meningitis groups compared to West syndrome and control groups.
  • CSF HMGB1 levels showed positive correlations with interleukin-6 and -8.
  • CSF HMGB1 levels correlated with VEGF, and PDGF also showed a positive relationship.

Conclusions:

  • HMGB1 and angiogenesis-related growth factors are implicated in the pathophysiology of CNS infections in children.
  • These molecules may serve as important biomarkers or therapeutic targets in pediatric neurological infections.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K